For individuals facing Transthyretin Amyloid Cardiomyopathy (ATTR-CM), a serious condition, the emergence of this treatment and the formulated version represents a genuine change. These groundbreaking therapies protect the transthyretin protein, preventing its destructive build-up and alleviating the impact of the disease . Individuals are now expe